SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is trending as the community debates the stock's role as a proxy for political sentiment, amidst active discussions surrounding its high volatility and the implications of company-related crypto ventures. Investors and traders are closely watching price action and speculative momentum, with polarized community sentiment reflecting broader debates over the company's valuation, leadership, and the influence of national political discourse on its market performance.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is trending due to the company's recent strategic push into the physical AI and robotics sector, underscored by new partnerships and the recent Rev8 LiDAR platform receiving critical regulatory compliance that unlocks federal infrastructure project access. Community sentiment remains focused on the company's role as a 'picks-and-shovels' provider for autonomous systems, though discourse is split between long-term bullish conviction in its technological moat and skepticism regarding short-term volatility and past share dilution.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

Churchill Capital Corp XI is trending as investors aggressively reprice the stock, driven by a 5.6% stake disclosure from BlueCrest Capital and growing momentum behind Agility Robotics as a leading U.S. humanoid robotics play. Community members are actively comparing the stock's pre-merger phase to previous high-growth SPAC successes like ASTS and OKLO, while debating the firm's commercial deployment pipeline with major partners like Amazon and NVIDIA.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

GE Vernova is surging as strong electrification demand and a massive order backlog fuel investor confidence in its role as a critical power infrastructure provider for AI data centers. The stock is seeing significant institutional interest and positive momentum following strong earnings, with market participants closely monitoring its strategic positioning in the grid modernization cycle.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending due to market volatility sparked by reports that Meta Platforms may monetize its own excess AI compute capacity, which has fueled investor concerns about potential competition for independent cloud providers. While the community is debating whether this signals a long-term threat or a temporary overreaction, bullish investors continue to emphasize the company's massive multi-year backlog and ironclad contracts as a foundation for long-term growth despite the current sector-wide repricing.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors react to the newly scheduled FDA Advisory Committee meeting for its lead DMD candidate, Deramiocel, alongside the release of positive five-year study data. While some community members view the meeting as a potential hurdle, many bulls interpret the public forum as a strategic opportunity to solidify a broad label approval ahead of the PDUFA date.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is experiencing intense volatility and downward pressure as investors rotate out of semiconductor and tech holdings due to escalating geopolitical tensions in the Middle East and concerns over stretched AI valuations. The community is actively debating whether current price levels represent a high-conviction discount buying opportunity or a deeper correction for this leveraged ETF.

Anthropic

Anthropic is trending due to reports that it is in talks with Samsung to manufacture custom AI server chips, alongside intense market attention surrounding its confidential IPO filing and ongoing government efforts to regulate its advanced Claude models. The community is actively debating the startup's rapid valuation growth, its potential IPO timeline, and the implications of its deep-pocketed infrastructure partnerships with tech giants.

Terrestrial Energy, Inc. is an advanced nuclear technology company focused on next-generation nuclear energy systems. The company is developing the Integral Molten Salt Reactor (IMSR), an innovative type of Generation IV molten salt reactor designed to produce reliable, low-carbon heat and electricity at competitive costs. The company is headquartered in Charlotte, NC.

Terrestrial Energy Inc.

Terrestrial Energy is garnering investor attention as a key infrastructure play in the nuclear sector, bolstered by a strategic collaboration with Riot Platforms to develop nuclear-powered data centers. Community discussion is focused on the company's differentiated molten salt technology, potential for recurring revenue, and its pivot toward powering the surging energy demands of AI hyperscalers.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektar Therapeutics is seeing significant investor attention driven by strong data from its maintenance study for rezpegaldesleukin, which demonstrated long-term durability and efficacy in atopic dermatitis patients. The community is actively debating the stock's potential for future buyouts or partnerships, while sentiment remains split between long-term bulls encouraged by the clinical progress and skeptics wary of the company's past history and recent dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
